MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Rhythm Pharmaceuticals, Inc. Common Stock

RYTM

#1020
Rhythm Pharmaceuticals, Inc. Common Stock
92.7300
-4.28%
Sector:
Base:
Profit Currency:
Daily Range
92.7300
92.8300
Year Range
95.0000
122.2000
Daily Change
-4.28%
Monthly Change
-11.82%
6 month change
-15.94%
Year Change
-15.94%
Previous Close
96.8800
Open
92.8300
Bid
Ask
Low
92.7300
High
92.8300
Volume
161
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. RYTM
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 202020212022202320242025 TTM

News

Investing Investing
RYTM
yesterday, 12:45
Guggenheim raises Rhythm Pharmaceuticals stock price target on guidance
Investing Investing
RYTM
yesterday, 10:25
Citizens raises Rhythm Pharmaceuticals stock price target on HO approval outlook
Investing Investing
RYTM
2 days ago, 18:10
Stifel reiterates Buy on Rhythm Pharmaceuticals stock, $131 target
Zacks Zacks
RYTM QURE
2 days ago, 14:55
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q4 Loss, Beats Revenue Estimates
Investing Investing
RYTM
2 days ago, 14:44
Rhythm Pharma Q4 2025 slides: revenue beats as HO launch nears
Investing Investing
RYTM
2 days ago, 12:51
Rhythm Pharma earnings beat by $0.09, revenue topped estimates
Zacks Zacks
RYTM SRPT
2026.02.19
Rhythm Pharmaceuticals, Inc. (RYTM) Expected to Beat Earnings Estimates: Should You Buy?
Benzinga Benzinga
RYTM
2026.02.19
Rhythm Pharmaceuticals Could Capture Big Share Of Rare Obesity Market - Rhythm Pharmaceuticals (NASDAQ:RYTM)
Investing Investing
RYTM
2026.02.18
RBC Capital initiates Rhythm Pharmaceuticals stock with outperform rating
Zacks Zacks
RARE RYTM
2026.02.12
Ultragenyx (RARE) Reports Q4 Loss, Beats Revenue Estimates
Investing Investing
RYTM
2026.02.11
Rhythm Pharmaceuticals at Guggenheim Summit: Expanding Horizons in Biotech
Investing Investing
RYTM
2026.02.07
Smith, Rhythm Pharmaceuticals CFO, sells $702k in RYTM stock

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd